Found: 4
Select item for more details and to access through your institution.
EMA commentary on the guideline on quality, nonclinical and clinical aspects of medicinal products containing genetically modified cells.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 5, p. 1203, doi. 10.1111/bcp.16047
- By:
- Publication type:
- Article
Dual-regulated Lentiviral Vector for Gene Therapy of X-linked Chronic Granulomatosis.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 8, p. 1472, doi. 10.1038/mt.2014.87
- By:
- Publication type:
- Article
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease.
- Published in:
- Journal of Clinical Immunology, 2022, v. 42, n. 8, p. 1742, doi. 10.1007/s10875-022-01338-x
- By:
- Publication type:
- Article
Lentiviral vectors for the treatment of primary immunodeficiencies.
- Published in:
- Journal of Inherited Metabolic Disease, 2014, v. 37, n. 4, p. 525, doi. 10.1007/s10545-014-9690-y
- By:
- Publication type:
- Article